Mangaluru: New Kannada translation of Quran released

Bengaluru, Feb 6: A flower vendor from Channapatna town in Karnataka got a shock of his life when he found a credit of Rs 30 crore in his wife's bank account. This happened when Syed Malik Burhan was struggling to meet expenses for a medical emergency in the family.

According to reports, bank officials knocked on his doors on December 2 asking him to explain how the money came to his account.

"On December 2, they came searching our house. They only said a huge amount has been deposited in my wife's (Rehana) account and then asked me to come to the Bank along with my wife carrying Aadhaar card," Mr Burhan said.

He claimed that the Bank staff sought to exert pressure on him to sign on a document but he refused. Mr Burhan recalled that he had purchased a saree through an online portal following which he received a call seeking his bank details which, he was told, were needed as he had won a car.

"Since then, we are running from pillars to post to find out how the money came to our account. We had only Rs 60 but suddenly such huge money came, which we are unable to understand," said Mr Burhan.

Mr Burhan said he had lodged a complaint with the Income Tax department, which he claimed was not keen on investigating it initially. Based on his complaint, the Channapatna town police in Ramanagara district registered a case of forgery and impersonation under the IPC besides the Information Technology Act for cheating and impersonation on January nine.

According to police, there were many financial transactions, which Mr Burhan may be unaware of. "We are trying to find out what these transactions mean. We will arrest whoever is behind it. We will not spare them," said a police officer in Channapatna.

Bengaluru, Jun 5: Karnataka Chief Minister B S Yediyurappa on Thursday said government employees and owners of tractors and other vehicles must return the BPL ration cards immediately, failing which stringent legal action would be initiated against them.

The CM issued directions in this regard to officials as he conducted a review meeting of the Food and Civil Supplies and Consumer Affairs department today. Proper supply of ration must be ensured to eligible beneficiaries and action has to be taken to prevent misuse of the facility by those not eligible, Yediyurappa was quoted as saying by his office in a release.

Nearly 63,000 ration cards were cancelled before the COVID-19 outbreak, he noted and directed officials to initiate a campaign to cancel all illegal ration cards. "this campaign would help in curtailing the financial burden on the State's reserves," he added.

In the backdrop of coronavirus pandemic, both the Central and State governments have distributed sufficient quantities of ration, and about 95 percent ration cardholders have availed the benefit, the release said. Under the Chief Ministers Anila Bhagya Scheme, 98,079 beneficiaries have been given 3 gas cylinders free of cost, it said.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.